Association between polymorphisms in TLR3, TICAM1 and IFNA1 genes and covid-19 severity in Southern Brazil

References

• Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–758. doi: 10.1136/postgradmedj-2020-138234
   PubMed Web of Science ®Google Scholar
• Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184(7):1671–1692. doi: 10.1016/j.cell.2021.02.029
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718–724. doi: 10.1126/science.abc6027
   PubMed Web of Science ®Google Scholar
• Totura AL, Whitmore A, Agnihothram S, et al. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. MBio. 2015;6(3):1–14. doi: 10.1128/mBio.00638-15
   Web of Science ®Google Scholar
• Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184(7):1671–1692. doi: 10.1016/j.cell.2021.02.029
   PubMed Web of Science ®Google Scholar
• Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and macrophages in COVID-19. Front Immunol Frontiers Media SA. 2021;12. doi: 10.3389/fimmu.2021.720109
   Google Scholar
• Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M, et al. Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients. Inflammopharmacology. 2022;30(5):1645–1657. doi: 10.1007/s10787-022-01029-4
   PubMed Web of Science ®Google Scholar
• Lamontagne F, Agoritsas T, MacDonald H, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379.
   PubMedGoogle Scholar
• Smatti MK, Al-Sarraj YA, Albagha O, et al. Host genetic variants potentially associated with SARS-CoV-2: a multi-population analysis. Front Genet. 2020;11:1064. doi: 10.3389/fgene.2020.578523
   Web of Science ®Google Scholar
• Rokni M, Sarhadi M, Heidari Nia M, et al. Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID-19 risk and severity in an Iranian population. Cell Biol Int. 2022;46(7):1109–1127. doi: 10.1002/cbin.11807
   PubMed Web of Science ®Google Scholar
• Moura EC, Cortez-Escalante J, Cavalcante FV, et al. Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020-2022. Rev Saude Publica. 2022;56:105. doi: 10.11606/s1518-8787.2022056004907
   PubMed Web of Science ®Google Scholar
• Solé X, Guinó E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–1929. doi: 10.1093/bioinformatics/btl268
   PubMed Web of Science ®Google Scholar
• Silva MJA, Vieira MDS, Souza AB, et al. Analysis of associations between the TLR3 SNPs rs3775291 and rs3775290 and COVID-19 in a cohort of professionals of Belém-PA, Brazil. Front Cell Infect Microbiol. 2023;13:1320701. doi: 10.3389/fcimb.2023.1320701
   PubMed Web of Science ®Google Scholar
• Dhangadamajhi G, Rout R. Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study. Hum Cell. 2021;34(3):1025–1027. doi: 10.1007/s13577-021-00510-6
   PubMed Web of Science ®Google Scholar
• Pati A, Padhi S, Chaudhury S, et al. TLR3 (rs3775291) variant is not associated with SARS-CoV-2 infection and related mortality: a population-based correlation analysis. Hum Cell. 2021;34(4):1274–1277. doi: 10.1007/s13577-021-00530-2
   PubMed Web of Science ®Google Scholar
• Ranjith-Kumar CT, Miller W, Sun J, et al. Effects of single nucleotide polymorphisms on toll-like receptor 3 activity and expression in cultured cells. J Biol Chem. 2007;282(24):17696–17705. doi: 10.1074/jbc.M700209200
   PubMed Web of Science ®Google Scholar
• Kindberg E, Vene S, Mickiene A, et al. A functional toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. J Infect Dis. 2011;203(4):523–528. doi: 10.1093/infdis/jiq082
   PubMed Web of Science ®Google Scholar
• Wang T, Yang J, Ji X, et al. Pathway analysis for a genome-wide association study of pneumoconiosis. Toxicol Lett. 2015;232(1):284–292. doi: 10.1016/j.toxlet.2014.10.028
   PubMed Web of Science ®Google Scholar
• Duzkale H, Shen J, Mclaughlin H, et al. A systematic approach to assessing the clinical significance of genetic variants. Clin Genet. 2013;84(5):453–463. doi: 10.1111/cge.12257
   PubMed Web of Science ®Google Scholar
• Collin RWJ, de Heer AMR, Oostrik J, et al. Mid-frequency DFNA8/12 hearing loss caused by a synonymous TECTA mutation that affects an exonic splice enhancer. Eur J Hum Genet. 2008;16(12):1430–1436. doi: 10.1038/ejhg.2008.110
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Haralambieva IH, Vierkant RA, et al. The role of polymorphisms in toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet. 2011;130(4):547–561. doi: 10.1007/s00439-011-0977-x
   PubMed Web of Science ®Google Scholar
• Fricke-Galindo I, Buendía-Roldán I, Ruiz A, et al. TNFRSF1B and TNF variants are associated with differences in levels of soluble tumor necrosis factor receptors in patients with severe COVID-19. J Infect Dis. 2022;226(5):778–787. doi: 10.1093/infdis/jiac101
   PubMed Web of Science ®Google Scholar
• Ali HN, Niranji SS, Sma A-J. Association of tumor necrosis factor alpha -308 single nucleotide polymorphism with SARS CoV-2 infection in an Iraqi Kurdish population. J Clin Lab Anal. 2022;36(5). doi: 10.1002/jcla.24400
   Web of Science ®Google Scholar
• Heidari Nia M, Rokni M, Mirinejad S, et al. Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses. J Med Virol. 2022;94(4):1502–1512. doi: 10.1002/jmv.27477
   PubMed Web of Science ®Google Scholar
• Saleh A, Sultan A, Elashry MA, et al. Association of TNF-α G-308 a promoter polymorphism with the course and outcome of COVID-19 Patients. Immunol Invest. 2020;51(3):546–557. doi: 10.1080/08820139.2020.1851709
   PubMed Web of Science ®Google Scholar
• Hegazi HM, Elghonemy MS, El-Baiomy MA, et al. Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients. Leuk Res. 2022;117:106854. doi: 10.1016/j.leukres.2022.106854
   PubMed Web of Science ®Google Scholar
• El-Raheem TA, Mahmoud RH, Hefzy EM, et al. Tumor necrosis factor (TNF)-α- 308 G/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis. PLOS ONE. 2020;15(12):15. doi: 10.1371/journal.pone.0240221
   Web of Science ®Google Scholar
• Bakr NM, Hashim NA, El-Baz HAED, et al. Polymorphisms in proinflammatory cytokines genes and susceptibility to Multiple Sclerosis. Mult Scler Relat Disord. 2021;47:102654. doi: 10.1016/j.msard.2020.102654
   PubMed Web of Science ®Google Scholar
• Abdel Galil SM, Ezzeldin N, Fawzy F, et al. The single-nucleotide polymorphism (SNP) of tumor necrosis factor α −308G/A gene is associated with early-onset primary knee osteoarthritis in an Egyptian female population. Clin Rheumatol. 2017;36(11):2525–2530. doi: 10.1007/s10067-017-3727-1
   PubMed Web of Science ®Google Scholar
• Youssef DM, El-Shal AS, Hussein S, et al. Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome. Cytokine. 2018;102:76–82. doi: 10.1016/j.cyto.2017.06.021
   PubMed Web of Science ®Google Scholar
• Hussein A, Askar E, Badawy A, et al. Impact of cytokine genetic polymorphisms on the risk of renal parenchymal infection in children. J Pediatr Urol. 2017;13(6):.e593.1–.e593.10. doi: 10.1016/j.jpurol.2017.05.025
   Web of Science ®Google Scholar
• Salanti G, Amountza G, Ntzani EE, et al. Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–848. doi: 10.1038/sj.ejhg.5201410
   PubMed Web of Science ®Google Scholar
• Hosking L, Lumsden S, Lewis K, et al. Detection of genotyping errors by hardy–weinberg equilibrium testing. Eur J Hum Genet. 2004;12:395–399. doi: 10.1038/sj.ejhg.5201164
   PubMed Web of Science ®Google Scholar
• Rana BK, Flatt SW, Health DD, et al. The IL-6 gene promoter SNP and plasma IL-6 in response to diet intervention. Nutrients. 2017;9(6):552. doi: 10.3390/nu9060552
   PubMed Web of Science ®Google Scholar
• Khafaei M, Asghari R, Zafari F, et al. Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients. Cytokine. 2024;174:156445. doi: 10.1016/j.cyto.2023.156445
   PubMed Web of Science ®Google Scholar
• Rodrigues FBB, da Silva R, Santos ED, et al. Association of polymorphisms of IL-6 pathway genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population. Viruses. 2023;15(5):1197. doi: 10.3390/v15051197
   PubMed Web of Science ®Google Scholar
• Verma S, Verma S, Khan FH, et al. Genetic polymorphisms of IL6 gene –174G > C and –597G > a are associated with the risk of COVID-19 severity. Int J Immunogenet. 2023;50(1):5–11. doi: 10.1111/iji.12605
   PubMed Web of Science ®Google Scholar
• Falahi S, Zamanian MH, Feizollahi P, et al. Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population. Cytokine. 2022;154:155889. doi: 10.1016/j.cyto.2022.155889
   PubMed Web of Science ®Google Scholar
• Reis PG, Ambrosio-Albuquerque EP, Fabreti-Oliveira RA, et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 profile in a population from southern Brazil. HLA. 2018;92:298–303. doi: 10.1111/tan.13368
   PubMed Web of Science ®Google Scholar